1,4-Bis(3-aminopropyl)piperazme libraries: From the discovery of classical chloroquine-like antimalarials to the identification of new targets

Combinatorial Chemistry and High Throughput Screening

Volumn 8, Issue 1, 2005, Pages 39-48

  Deprez Poulain, Rebecca ^a   Melnyk, Patricia ^b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b CNRS   (France)

Author keywords

4 aminoquinoline; Antimalarials; Benzimidazole; Chemogenomics; Pfa M1; Piperazine

Indexed keywords

1,4 BIS(3 AMINOPROPYL)PIPERAZINE DERIVATIVE; 4 AMINOQUINOLINE DERIVATIVE; AMINOPEPTIDASE INHIBITOR; ANTIMALARIAL AGENT; CHLOROQUINE; CYTOSOL AMINOPEPTIDASE; CYTOSOL AMINOPEPTIDASE PFA M1; HEMATIN; N1,N2 BIS(7 CHLORO 4 QUINOLINYL) 1,2 CYCLOHEXANEDIAMINE; PIPERAQUINE; PIPERAZINE DERIVATIVE; SULFONAMIDE; UNCLASSIFIED DRUG;

DRUG SCREENING; DRUG TARGETING; EVALUATION; FLUORESCENCE; LIBRARY; MALARIA; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SYNTHESIS; VALIDATION PROCESS;

ANTIMALARIALS; PIPERAZINES;

EID: 12744274985     PISSN: 13862073     EISSN: None     Source Type: Journal    
DOI: 10.2174/1386207053328165     Document Type: Review

References (83)

1. 1.22 million deaths in 2002 (World Health Organisation Global report 2002).
2. Maitland, K.; Marsh, K. Acta Tropica 2004, 90, 131-140.
3. For a review on severe malaria treatment and clinical trials of malaria vaccines: Maitland, K.; Bejon, P.; Newton, C.R.J.C. Curr. Opin. Infect. Dis. 2003, 16, 389-395.
4. White, N.J. N. Engl. J. Med. 1996, 335, 800-806.
5. Basco, L.K.; Ndounga, M.; Keundjian, A.; Ringwald, P. Am. J. Trop. Med. Hyg. 2002, 66, 117-123.
6. Bloland, P.B. Drug resistance in malaria, a WHO report, 2001.
7. Phillips, M.; Phillips-Howard, P.A. Pharmacoeconomics. 1996, 10, 225-238.
8. Hyde, J.E. Microbes and Infection 2002, 4, 165-174.
9. James, S.; Miller, L. Malaria Vaccine Development: Status report, NIAID, 2001.
10. Woster, P.M. New Therapies for Malaria in Ann. Reports Med. Chem. Vol. 38, Editor Doherty, A.M. Academic Press, New York, 2003, 203-211.
11. For a review on chemotherapy research: Wiesner, J.; Ortmann, R.; Jomaa, H.; Schitser, M. Angew. Chem. Int. Ed. 2003, 42, 5274-5293.
12. Egan, T.J. Drug Design Reviews-Online 2004, 1, 93-110.
13. (a) Egan, T.J. Mini. Rev. Med. Chem. 2001, 11, 113-123;
14. (b) O'Neill, P.M.; Mukhtar, A.; Stocks, P.A.; Randle, L.E.; Hindley, S.; Ward, S.A.; Storr, R.C.; Bickley, J.F.; O'Neil, I.A.; Maggs, J.L.; Hughes, R.H.; Winstanley, P.A.; Bray, P.G.; Park, B.K. J. Med. Chem. 2003, 46, 4933-4945.
15. Ridley, R.G.; Matile, H.; Jaquet, C.; Dorn, A.; Hofheinz, W.; Leupin, W.; Masciadri, R.; Theil, F.-P.; Richter, W.F.; Girometta, M.-A.; Guenzi, A.; Urwyler, H.; Gocke, E.; Potthast, J.-M.; Csato, M.; Thomas, A.; Peters, W. Antimicrob. Agents Chemother. 1997, 41, 677-686.
16. Raynes, K.; Galatis, D.; Cowman, A.F.; Tilley, L.; Deady, L.W. J. Med. Chem. 1995, 38, 204-206.
17. Girault, S.; Grellier, P.; Berecibar, A.; Maes, L.; Lemiere, P.; Mouray, E.; Davioud-Charvet, E.; Sergheraert, C. J. Med. Chem. 2001, 44, 1658-1665.
18. Unpublished results. Similar studies on linkers were performed with bis-acridines and published: Girault, S.; Grellier, P.; Berecibar, A.; Maes, L.; Mouray, E.; Lemiere, P.; Debreu, M.-A.; Davioud-Charvet, E.; Sergheraert, C. J. Med. Chem. 2000, 13, 2646-2654.
19. Guillon, J.; Grellier, P.; Labaied, M.; Sonnet, P.; Leger, J.-M.; Deprez-Poulain, R.; Forfar-Bares, I.; Dallemagne, P.; Lemaitre, N.; Pehourcq, F.; Rochette, J.; Sergheraert, C.; Jarry, C. J. Med. Chem. 2004, 47, 1997-2009.
20. Ryckebusch, A.; Deprez-Poulain, R.; Debreu-Fontaine, M.-A.; Vandaele, R.; Mouray, E.; Grellier, P.; Sergheraert, C. Bioorg. Med. Chem. Lett. 2002, 12, 2595-2598.
21. Ryckebusch, A.; Deprez-Poulain, R.; Maes, L.; Debreu-Fontaine, M.-A.; Mouray, E.; Grellier, P.; Sergheraert, C. J. Med. Chem. 2003, 46, 542-557.
22. Ryckebusch, A.; Deprez-Poulain, R.; Debreu-Fontaine, M.-A.; Vandaele, R.; Mouray, E.; Grellier, P.; Sergheraert, C. Bioorg. Med. Chem. Lett. 2003, 13, 3783-3787.
23. Fidock, D.A.; Rosenthal, P.J.; Croft, S.L.; Brun, R.; Nwaka, S. Nature Reviews, Drug Discovery, 2004, 3, 509-520.
24. Zamora, J. M.; Pearce, H. L.; Beck, W. T. Mol. Pharmacol. 1988, 33, 454-462.
25. Hawley, S.; Bray, P. G.; O'Neill, P. M.; Park, B. K.; Ward, S. A. Biochem. Pharmacol. 1996, 52, 723-733.
26. Hawley, S.; Bray, P. G.; Park, B. K.; Ward, S. A. Mol. Biochem. Parasitol. 1996, 80, 15-25.
27. pKa can be calculated with the software ACD/pKa DB from Avanced Chemistry Development Inc., Toronto, Canada. The database can be implemented with measured pKa values so that the calculations are more accurate in the chemical series of interest.
28. For a review on the formation of hemozoin: Sullivan, D.J. Int. J. Parasitol. 2002, 32, 1645-1653.
29. Tripathi, A.K.; Khan, S.I.; Walker, L.A.; Tekwani, B.L. Anal. Biochem. 2004, 325, 85-91.
30. (a) Parapini, S.; Basilico, N.; Pasini, E.; Egan, T.J.; Olliaro, P.; Taramelli, D.; Monti, D. Exp. Parasitol. 2000, 96, 249-256.;
31. (b) Basilico, N.; Pagani, E.; Monti, D.; Olliaro, P.; Taramelli, D. J. Antimicrob. Chemother. 1998, 42, 55-60.
32. Kurosawa, Y.; Dorn, A.; Kitsuji-Shirane, M.; Shimada, H.; Satoh, T.; Matile, H.; Hofheinz, W.; Masciadri, R.; Kansy, M.; Ridley, R.G. Antimicrob. Agents Chemother. 2000, 44, 2638-2644.
33. Pandey, A.V.; Singh, N.; Tekwani, B.L.; Puri, S.K.; Chauhan, V.S. J. Pharm. Biomed. Anal. 1999, 20, 203-207.
34. Fitch, C. D.; Cai, G.; Chen, Y.-F.; Shoemaker, J. D. Biochim. Biophys. Acta 1999, 1454, 31-37.
35. Fitch, C.D. Life Sciences 2004, 74, 1957-1972.
36. Ayad, F.; Tilley, L.; Deady, L.-W. Bioorg. Med. Chem. Lett. 2001, 11, 2075-2077.
37. Kalkanidis, M.; Klonis, N.; Tilley, L.; Deady, L.W. Biochem. Pharmacol. 2002, 63, 833-842.
38. Wright, A.D.; Wang, H.; Gurrath, M.; König, G. M.; Kocak, G.; Neumann, G.; Loria, P.; Foley, M.; Tilley, L. J. Med. Chem. 2001, 44, 873-885.
39. Wiesner, J.; Wissner, P.; Dahse, H-M; Jomaa, H.; Schlizer, M. Bioorg. Med. Chem. 2001, 9, 785-792.
40. Srinivasan, T.; Srivastava, G.K.; Pathak, A.; Batra, S.; Raj Kshipra Singh, K.; Puri, S.K.; Kundu, B. Bioorg. Med. Chem. Lett. 2002, 12, 2803-2806.
41. Leban, J.; Pegoraro, S.; Dormeyer, M.; Lanzer, M.; Aschenbrenner, A.; Kramer, B. Bioorg. Med. Chem. Lett. 2004, 14, 1979-1982.
42. Labadie, G.R.; Choi, S.-R.; Avery, MA. Bioorg. Med. Chem. Lett. 2004, 14, 615-619.
43. Soulère, L.; Delplace, P.; Davioud-Charvet, E.; Py, E.; Sergheraert, C.; Périé, J.; Ricard, I.; Hoffmann, P.; Dive, D. Bioorg. Med. Chem. 2003, 11, 4941-4944.
44. Vilaivan, T.; Saesaengseerung, N.; Jarprung, D.; Kamchonwongpaisan, S.; Sirawaraporn, W.; Yuthavong, Y. Bioorg. Med. Chem., 2003, 11, 217-224.
45. Dahlgren, A.; Kvarnström, I.; Vrang, L.; Hamelink, E.; Hallberg, A.; Rosenquist, A.; Samuelsson, B. Bioorg. Med. Chem. 2003, 11, 827-841.
46. Noteberg, D.; Schaal, W.; Hamelink, E.; Vrang, L.; Larhed, M.; J. Comb. Chem. 2003, 5, 456-464.
47. Choi, C.Y.H.; Schneider, E.L.; Kim, J.M.; Gluzman, I.Y.; Goldberg, D.E.; Ellman, JA.; Marietta, MA. Chem. Biol. 2002, 9, 881-889.
48. Liao, X.B.; Han, J.Y.; Li, Y. Tetrahedron Lett. 2001, 42, 2843-2845.
49. Skinner-Adams, T.S.; Davis, T.M.; Manning, L.S.; Johnston, WA. Trans. R. Soc. Trop. Med. Hyg. 1997, 91, 580-584.
50. Howarth, J.; Hanlon, K. Tetrahedron Lett. 2001, 42, 751-754.
51. Riel, MA.; Kyle, D.E.; Bhattacharjee, A.K.; Milhous, W.K. Antimicrob. Agents Chemother. 2002, 46, 2627-2632.
52. Tamta, H.; Mukhopadhyay, A.K. CREPS 2003, 4, 6-9.
53. Nature, Plasmodium genomics special issue, 3rd October 2002.
54. Leung, D.; Abbenante, G.; Fairlie, O.P. J. Med. Chem. 2000, 43, 305-341.
55. Acharya, K.R.; Sturrock, E.D.; Riordan, J.F.; Ehlers, M.R.W. Nature Reviews, Drug Discovery. 2003, 2, 891-902
56. Rodriguez-Barrios, F.; Gago, F. Curr Top Med Chem. 2004, 4, 991-1007.
57. Rosenthal, P. J. Curr. Opin. Hematol. 2002, 9, 140-145.
58. Blackman, M. J. Curr. Drug Targets. 2000, 1, 59-83.
59. Banerjee, R., Liu, J.; Beatty, W.; Pelosof, L.; Klemba, M.; Goldberg, D.E. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 990-995.
60. (a) Rosenthal, P.J.; Sijwali, P.S.; Singh, A.; Shenai, B.R. Curr. Pharm. Des. 2002,5, 1659-1672.
61. (b) Dash, C.; Kulkarni, A.; Dunn, B.; Rao, M. Crit. Rev. Biochem. Mol. Biol. 2003, 38, 89-119.
62. Eggleson, K.K.; Duffm, K.L.; Goldberg, D.E. J. Biol. Chem. 1999, 274, 32411-32417.
63. Florent, I.; Derhy, Z.; Allary, M.; Monsigny, M.; Mayer, R.; Schrevel, J. Mol. Biochem. Parasitol. 1998, 97, 149-160.
64. Johansson, P.-O.; Chen, Y.; Belfrage, A.K.; Blackman, M.J., Kvarnström, I.; Jansson, K.; Vrang, L.; Hamelink, E.; Hallberg, A.; Rosenquist, A.; Samuelsson, B. J. Med. Chem. 2004, 47, 3353-3366.
65. Sijwali, P.S.; Rosenthal, P.J. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 4384-4389.
66. Greenbaum, D.C.; Baruch, A.; Grainger, M.; Bozdech, Z.; Medzihradsky, K.F.; Engel, J.; DeRisi, J.; Holder, A.A.; Bogyo, M. Science, 2002, 298, 2002-2006.
67. Sijwali, P.S.; Kato, K.; Seydel, K.B.; Gut, J.; Lehman, J.; Klemba, M.; Goldberg, D.E.; Miller, L.H.; Rosenthal, P.J. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 8721-8726.
68. Salmon, B.L.; Oksman, A.; Goldberg, D.E. Proc. Natl. Acad. Sci. U.S.A. 2001, 95, 271-276.
69. Murata, C.E.; Goldberg, D.E. J. Biol. Chem. 2003, 275, 38022-38028.
70. Withers-Martinez, C.; Jean, L.; Blackman, M.J. Mol. Microbiol. 2004, 53 (1), 55-63.
71. Kolakovich, K.A.; Gluzman, I.Y.; Duffin, K.L.; Goldberg, D.E. Mol. Biochem. Parasitol. 1997, 57, 123-135.
72. (a) Noteberg, D.; Schaal, W.; Hamelink, E.; Vrang, L.; Larhed, M. J. Comb. Chem. 2003, 5, 456-464.
73. (b) Haque, T.S.; Skillman, A.G.; Lee, C.E.; Habashita, H.; Gluzman, I.Y.; Ewing, T.J.A.; Goldberg, D.E.; Kuntz, I.D.; Ellman, J.A. J. Med. Chem. 1999, 42. 1428-1440.
74. Ersmark, K..; Feierberg, I.; Bjelic, S.; Hamelink, E.; Hacken, F.; Blackman, M.J.; Hulten, J.; Samuelsson, B.; Aqvist, J.; Hallberg. J. Med. Chem. 2004, 47, 110-22.
75. Chiyanzu, I.; Hansell, E.; Gut, J.; Rosenthal, P.J.; McKerrow, J.H.; Chibale, K. Bioorg. Med. Chem. Lett. 2003, 13, 3527-3530.
76. Ersmark, K.; Felerberg, I.; Bjelic, S.; Hamelink, E.; Hackett, F.; Blackman, M.J.; Hulten, J.; Samuelsson, B.; Aqvist, J.; Hallberg, A. Antimicrob. Agents Chemother. 2003, 47, 154-160.
77. Batra, S.; Sabnis, Y.A.; Rosenthal, P.J.; Avery, M.A. Bioorg. Med. Chem. 2003, 11, 2293-2299.
78. Gavigan, C.S.; Machado, S.G.; Dation, J.P.; Bell, A. Antimicrob. Agents Chemother. 2001, 45, 3175-3181.
79. PhD work of Ryckebusch, A. (2002, University of Lille2, France).
80. Allary, M.; Schrevel, J.; Florent, I. Parasitology 2002, 125, 1-10.
81. Flipo, M.; Florent, I.; Grellier, P.; Sergheraert, C.; Deprez-Potilain, R. Bioorg. Med. Chem. Lett 2003, 13, 2659-2662.
82. Whittaker, M.; Floyd, C.D.; Brown, P.; Gearing, A.J.H. Chem. Rev. 1999, 99, 2735-2776.
83. PhD work of Allary. M. (2003, University of Lille2, France).